https://www.selleckchem.com/pr....oducts/tuvusertib.ht
Western blotting was used to determine the extent of Akt and eNOS phosphorylation. Contrary to PA that caused an increase in the reactive oxygen species (ROS) levels and attenuated NO production, CSE readjusted the NO/ROS ratio within 12h. CSE improved the metabolic arm of the insulin signaling pathway by up-regulating the insulin-stimulated phospho-eNOS Ser1177/total eNOS and phospho-Akt Thr308/total Akt ratios and decreased ET-1 levels. CSE ameliorated the PA-induced endothelial dysfunction not only by its anti-ROS property but als